ヒトアルブミン注射の世界市場成長率 2023-2029Global Human Albumin Injection Market Growth 2023-2029 ヒトアルブミン注射液の世界市場規模は、2022年の百万米ドルから2029年には百万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。 ヒトアルブミン注射液の米国市場は... もっと見る
サマリーヒトアルブミン注射液の世界市場規模は、2022年の百万米ドルから2029年には百万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予測されています。ヒトアルブミン注射液の米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。 ヒトアルブミン注射液の中国市場は、2023年から2029年までのCAGRで、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。 ヒトアルブミン注射液のヨーロッパ市場は、2023年から2029年にかけてのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。 ヒトアルブミン注射剤の世界主要メーカーは、Octapharma、CSL Behring、Biotest (UK) Ltd、Baxter、Kedrion Biopharma, Inc、Grifols、GE HealthCare、Bio Products Laboratory、Green Crossなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ%のシェアを占めています。 ヒトアルブミン溶液は、医療や外科のさまざまな問題で使用されています。 LPI(エルピーアイ)の最新リサーチレポート「ヒトアルブミン注射液の業界予測」は、過去の販売実績と2022年のヒトアルブミン注射液の世界総販売実績を調べ、2023年から2029年のヒトアルブミン注射液の販売予測について地域や市場分野ごとに包括的に分析したものである。ヒトアルブミン注射液の売上を地域別、市場分野別、サブセクター別に分類し、世界のヒトアルブミン注射液産業の詳細な分析を100万米ドル単位で提供します。 本インサイトレポートでは、世界のHuman Albumin Injectionの状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、ヒトアルブミン注射剤のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要なグローバル企業の戦略を分析し、加速する世界のヒトアルブミン注射剤市場におけるこれらの企業の独自の地位をより良く理解することができます。 本インサイトレポートでは、ヒトアルブミン注射剤の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を行い、機会の新たなポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界のヒトアルブミン注射剤の現状と将来の軌道について非常にニュアンスのある見方を提供します。 本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のヒトアルブミン注射剤市場の包括的な概要、市場シェア、成長機会について紹介します。 市場のセグメンテーション タイプ別セグメンテーション 血液抽出 リコンバイン 用途別セグメンテーション 病院 診療所 また、本レポートでは、地域別に市場を分割しています: 米州 アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス イギリス イタリア ロシア 中近東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。 オクタファーマ CSL ベーリング ビオテスト(UK)社 バクスター Kedrion Biopharma, Inc. グリフォルス GE ヘルスケア バイオプロダクツラボラトリー ミドリ十字 SKプラズマ インスティテュート・グリフォルス 武田薬品工業 花蘭咲バイオ 南岳生物製薬(Nanyue Biopharmaceuticals 本レポートで取り上げる主な質問 ヒトアルブミン注射液の世界市場の10年後の展望は? 世界および地域別に、ヒトアルブミン注射液市場の成長を促進する要因は何か? 市場別、地域別で最も急成長する技術は何か? ヒトアルブミン注射液の市場機会はエンドマーケットの規模によってどのように変化するのか? ヒトアルブミン注射液のタイプ別、用途別の内訳は? COVID-19とロシア・ウクライナ戦争の影響とは? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human Albumin Injection Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Human Albumin Injection by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Human Albumin Injection by Country/Region, 2018, 2022 & 2029 2.2 Human Albumin Injection Segment by Type 2.2.1 Blood Extraction 2.2.2 Recombine 2.3 Human Albumin Injection Sales by Type 2.3.1 Global Human Albumin Injection Sales Market Share by Type (2018-2023) 2.3.2 Global Human Albumin Injection Revenue and Market Share by Type (2018-2023) 2.3.3 Global Human Albumin Injection Sale Price by Type (2018-2023) 2.4 Human Albumin Injection Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Human Albumin Injection Sales by Application 2.5.1 Global Human Albumin Injection Sale Market Share by Application (2018-2023) 2.5.2 Global Human Albumin Injection Revenue and Market Share by Application (2018-2023) 2.5.3 Global Human Albumin Injection Sale Price by Application (2018-2023) 3 Global Human Albumin Injection by Company 3.1 Global Human Albumin Injection Breakdown Data by Company 3.1.1 Global Human Albumin Injection Annual Sales by Company (2018-2023) 3.1.2 Global Human Albumin Injection Sales Market Share by Company (2018-2023) 3.2 Global Human Albumin Injection Annual Revenue by Company (2018-2023) 3.2.1 Global Human Albumin Injection Revenue by Company (2018-2023) 3.2.2 Global Human Albumin Injection Revenue Market Share by Company (2018-2023) 3.3 Global Human Albumin Injection Sale Price by Company 3.4 Key Manufacturers Human Albumin Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Human Albumin Injection Product Location Distribution 3.4.2 Players Human Albumin Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Human Albumin Injection by Geographic Region 4.1 World Historic Human Albumin Injection Market Size by Geographic Region (2018-2023) 4.1.1 Global Human Albumin Injection Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Human Albumin Injection Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Human Albumin Injection Market Size by Country/Region (2018-2023) 4.2.1 Global Human Albumin Injection Annual Sales by Country/Region (2018-2023) 4.2.2 Global Human Albumin Injection Annual Revenue by Country/Region (2018-2023) 4.3 Americas Human Albumin Injection Sales Growth 4.4 APAC Human Albumin Injection Sales Growth 4.5 Europe Human Albumin Injection Sales Growth 4.6 Middle East & Africa Human Albumin Injection Sales Growth 5 Americas 5.1 Americas Human Albumin Injection Sales by Country 5.1.1 Americas Human Albumin Injection Sales by Country (2018-2023) 5.1.2 Americas Human Albumin Injection Revenue by Country (2018-2023) 5.2 Americas Human Albumin Injection Sales by Type 5.3 Americas Human Albumin Injection Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Human Albumin Injection Sales by Region 6.1.1 APAC Human Albumin Injection Sales by Region (2018-2023) 6.1.2 APAC Human Albumin Injection Revenue by Region (2018-2023) 6.2 APAC Human Albumin Injection Sales by Type 6.3 APAC Human Albumin Injection Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Human Albumin Injection by Country 7.1.1 Europe Human Albumin Injection Sales by Country (2018-2023) 7.1.2 Europe Human Albumin Injection Revenue by Country (2018-2023) 7.2 Europe Human Albumin Injection Sales by Type 7.3 Europe Human Albumin Injection Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Human Albumin Injection by Country 8.1.1 Middle East & Africa Human Albumin Injection Sales by Country (2018-2023) 8.1.2 Middle East & Africa Human Albumin Injection Revenue by Country (2018-2023) 8.2 Middle East & Africa Human Albumin Injection Sales by Type 8.3 Middle East & Africa Human Albumin Injection Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Human Albumin Injection 10.3 Manufacturing Process Analysis of Human Albumin Injection 10.4 Industry Chain Structure of Human Albumin Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Human Albumin Injection Distributors 11.3 Human Albumin Injection Customer 12 World Forecast Review for Human Albumin Injection by Geographic Region 12.1 Global Human Albumin Injection Market Size Forecast by Region 12.1.1 Global Human Albumin Injection Forecast by Region (2024-2029) 12.1.2 Global Human Albumin Injection Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Human Albumin Injection Forecast by Type 12.7 Global Human Albumin Injection Forecast by Application 13 Key Players Analysis 13.1 Octapharma 13.1.1 Octapharma Company Information 13.1.2 Octapharma Human Albumin Injection Product Portfolios and Specifications 13.1.3 Octapharma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Octapharma Main Business Overview 13.1.5 Octapharma Latest Developments 13.2 CSL Behring 13.2.1 CSL Behring Company Information 13.2.2 CSL Behring Human Albumin Injection Product Portfolios and Specifications 13.2.3 CSL Behring Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 CSL Behring Main Business Overview 13.2.5 CSL Behring Latest Developments 13.3 Biotest (UK) Ltd 13.3.1 Biotest (UK) Ltd Company Information 13.3.2 Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications 13.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Biotest (UK) Ltd Main Business Overview 13.3.5 Biotest (UK) Ltd Latest Developments 13.4 Baxter 13.4.1 Baxter Company Information 13.4.2 Baxter Human Albumin Injection Product Portfolios and Specifications 13.4.3 Baxter Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Baxter Main Business Overview 13.4.5 Baxter Latest Developments 13.5 Kedrion Biopharma, Inc. 13.5.1 Kedrion Biopharma, Inc. Company Information 13.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications 13.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Kedrion Biopharma, Inc. Main Business Overview 13.5.5 Kedrion Biopharma, Inc. Latest Developments 13.6 Grifols 13.6.1 Grifols Company Information 13.6.2 Grifols Human Albumin Injection Product Portfolios and Specifications 13.6.3 Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Grifols Main Business Overview 13.6.5 Grifols Latest Developments 13.7 GE HealthCare 13.7.1 GE HealthCare Company Information 13.7.2 GE HealthCare Human Albumin Injection Product Portfolios and Specifications 13.7.3 GE HealthCare Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 GE HealthCare Main Business Overview 13.7.5 GE HealthCare Latest Developments 13.8 Bio Products Laboratory 13.8.1 Bio Products Laboratory Company Information 13.8.2 Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications 13.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Bio Products Laboratory Main Business Overview 13.8.5 Bio Products Laboratory Latest Developments 13.9 Green Cross 13.9.1 Green Cross Company Information 13.9.2 Green Cross Human Albumin Injection Product Portfolios and Specifications 13.9.3 Green Cross Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Green Cross Main Business Overview 13.9.5 Green Cross Latest Developments 13.10 SK Plasma 13.10.1 SK Plasma Company Information 13.10.2 SK Plasma Human Albumin Injection Product Portfolios and Specifications 13.10.3 SK Plasma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 SK Plasma Main Business Overview 13.10.5 SK Plasma Latest Developments 13.11 Instituto Grifols 13.11.1 Instituto Grifols Company Information 13.11.2 Instituto Grifols Human Albumin Injection Product Portfolios and Specifications 13.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Instituto Grifols Main Business Overview 13.11.5 Instituto Grifols Latest Developments 13.12 Takeda 13.12.1 Takeda Company Information 13.12.2 Takeda Human Albumin Injection Product Portfolios and Specifications 13.12.3 Takeda Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Takeda Main Business Overview 13.12.5 Takeda Latest Developments 13.13 Hualan Bio 13.13.1 Hualan Bio Company Information 13.13.2 Hualan Bio Human Albumin Injection Product Portfolios and Specifications 13.13.3 Hualan Bio Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Hualan Bio Main Business Overview 13.13.5 Hualan Bio Latest Developments 13.14 Nanyue Biopharmaceuticals 13.14.1 Nanyue Biopharmaceuticals Company Information 13.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications 13.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Nanyue Biopharmaceuticals Main Business Overview 13.14.5 Nanyue Biopharmaceuticals Latest Developments 14 Research Findings and Conclusion 図表リストList of TablesTable 1. Human Albumin Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Human Albumin Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Blood Extraction Table 4. Major Players of Recombine Table 5. Global Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 6. Global Human Albumin Injection Sales Market Share by Type (2018-2023) Table 7. Global Human Albumin Injection Revenue by Type (2018-2023) & ($ million) Table 8. Global Human Albumin Injection Revenue Market Share by Type (2018-2023) Table 9. Global Human Albumin Injection Sale Price by Type (2018-2023) & (US$/Unit) Table 10. Global Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 11. Global Human Albumin Injection Sales Market Share by Application (2018-2023) Table 12. Global Human Albumin Injection Revenue by Application (2018-2023) Table 13. Global Human Albumin Injection Revenue Market Share by Application (2018-2023) Table 14. Global Human Albumin Injection Sale Price by Application (2018-2023) & (US$/Unit) Table 15. Global Human Albumin Injection Sales by Company (2018-2023) & (K Units) Table 16. Global Human Albumin Injection Sales Market Share by Company (2018-2023) Table 17. Global Human Albumin Injection Revenue by Company (2018-2023) ($ Millions) Table 18. Global Human Albumin Injection Revenue Market Share by Company (2018-2023) Table 19. Global Human Albumin Injection Sale Price by Company (2018-2023) & (US$/Unit) Table 20. Key Manufacturers Human Albumin Injection Producing Area Distribution and Sales Area Table 21. Players Human Albumin Injection Products Offered Table 22. Human Albumin Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Human Albumin Injection Sales by Geographic Region (2018-2023) & (K Units) Table 26. Global Human Albumin Injection Sales Market Share Geographic Region (2018-2023) Table 27. Global Human Albumin Injection Revenue by Geographic Region (2018-2023) & ($ millions) Table 28. Global Human Albumin Injection Revenue Market Share by Geographic Region (2018-2023) Table 29. Global Human Albumin Injection Sales by Country/Region (2018-2023) & (K Units) Table 30. Global Human Albumin Injection Sales Market Share by Country/Region (2018-2023) Table 31. Global Human Albumin Injection Revenue by Country/Region (2018-2023) & ($ millions) Table 32. Global Human Albumin Injection Revenue Market Share by Country/Region (2018-2023) Table 33. Americas Human Albumin Injection Sales by Country (2018-2023) & (K Units) Table 34. Americas Human Albumin Injection Sales Market Share by Country (2018-2023) Table 35. Americas Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions) Table 36. Americas Human Albumin Injection Revenue Market Share by Country (2018-2023) Table 37. Americas Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 38. Americas Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 39. APAC Human Albumin Injection Sales by Region (2018-2023) & (K Units) Table 40. APAC Human Albumin Injection Sales Market Share by Region (2018-2023) Table 41. APAC Human Albumin Injection Revenue by Region (2018-2023) & ($ Millions) Table 42. APAC Human Albumin Injection Revenue Market Share by Region (2018-2023) Table 43. APAC Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 44. APAC Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 45. Europe Human Albumin Injection Sales by Country (2018-2023) & (K Units) Table 46. Europe Human Albumin Injection Sales Market Share by Country (2018-2023) Table 47. Europe Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions) Table 48. Europe Human Albumin Injection Revenue Market Share by Country (2018-2023) Table 49. Europe Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 50. Europe Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 51. Middle East & Africa Human Albumin Injection Sales by Country (2018-2023) & (K Units) Table 52. Middle East & Africa Human Albumin Injection Sales Market Share by Country (2018-2023) Table 53. Middle East & Africa Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions) Table 54. Middle East & Africa Human Albumin Injection Revenue Market Share by Country (2018-2023) Table 55. Middle East & Africa Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 56. Middle East & Africa Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 57. Key Market Drivers & Growth Opportunities of Human Albumin Injection Table 58. Key Market Challenges & Risks of Human Albumin Injection Table 59. Key Industry Trends of Human Albumin Injection Table 60. Human Albumin Injection Raw Material Table 61. Key Suppliers of Raw Materials Table 62. Human Albumin Injection Distributors List Table 63. Human Albumin Injection Customer List Table 64. Global Human Albumin Injection Sales Forecast by Region (2024-2029) & (K Units) Table 65. Global Human Albumin Injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 66. Americas Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units) Table 67. Americas Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 68. APAC Human Albumin Injection Sales Forecast by Region (2024-2029) & (K Units) Table 69. APAC Human Albumin Injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 70. Europe Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units) Table 71. Europe Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 72. Middle East & Africa Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units) Table 73. Middle East & Africa Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Global Human Albumin Injection Sales Forecast by Type (2024-2029) & (K Units) Table 75. Global Human Albumin Injection Revenue Forecast by Type (2024-2029) & ($ Millions) Table 76. Global Human Albumin Injection Sales Forecast by Application (2024-2029) & (K Units) Table 77. Global Human Albumin Injection Revenue Forecast by Application (2024-2029) & ($ Millions) Table 78. Octapharma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 79. Octapharma Human Albumin Injection Product Portfolios and Specifications Table 80. Octapharma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 81. Octapharma Main Business Table 82. Octapharma Latest Developments Table 83. CSL Behring Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 84. CSL Behring Human Albumin Injection Product Portfolios and Specifications Table 85. CSL Behring Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 86. CSL Behring Main Business Table 87. CSL Behring Latest Developments Table 88. Biotest (UK) Ltd Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 89. Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications Table 90. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 91. Biotest (UK) Ltd Main Business Table 92. Biotest (UK) Ltd Latest Developments Table 93. Baxter Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 94. Baxter Human Albumin Injection Product Portfolios and Specifications Table 95. Baxter Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 96. Baxter Main Business Table 97. Baxter Latest Developments Table 98. Kedrion Biopharma, Inc. Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 99. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications Table 100. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 101. Kedrion Biopharma, Inc. Main Business Table 102. Kedrion Biopharma, Inc. Latest Developments Table 103. Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 104. Grifols Human Albumin Injection Product Portfolios and Specifications Table 105. Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 106. Grifols Main Business Table 107. Grifols Latest Developments Table 108. GE HealthCare Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 109. GE HealthCare Human Albumin Injection Product Portfolios and Specifications Table 110. GE HealthCare Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 111. GE HealthCare Main Business Table 112. GE HealthCare Latest Developments Table 113. Bio Products Laboratory Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 114. Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications Table 115. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 116. Bio Products Laboratory Main Business Table 117. Bio Products Laboratory Latest Developments Table 118. Green Cross Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 119. Green Cross Human Albumin Injection Product Portfolios and Specifications Table 120. Green Cross Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 121. Green Cross Main Business Table 122. Green Cross Latest Developments Table 123. SK Plasma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 124. SK Plasma Human Albumin Injection Product Portfolios and Specifications Table 125. SK Plasma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 126. SK Plasma Main Business Table 127. SK Plasma Latest Developments Table 128. Instituto Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 129. Instituto Grifols Human Albumin Injection Product Portfolios and Specifications Table 130. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 131. Instituto Grifols Main Business Table 132. Instituto Grifols Latest Developments Table 133. Takeda Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 134. Takeda Human Albumin Injection Product Portfolios and Specifications Table 135. Takeda Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 136. Takeda Main Business Table 137. Takeda Latest Developments Table 138. Hualan Bio Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 139. Hualan Bio Human Albumin Injection Product Portfolios and Specifications Table 140. Hualan Bio Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 141. Hualan Bio Main Business Table 142. Hualan Bio Latest Developments Table 143. Nanyue Biopharmaceuticals Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 144. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications Table 145. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 146. Nanyue Biopharmaceuticals Main Business Table 147. Nanyue Biopharmaceuticals Latest Developments List of Figures Figure 1. Picture of Human Albumin Injection Figure 2. Human Albumin Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Human Albumin Injection Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Human Albumin Injection Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Human Albumin Injection Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Blood Extraction Figure 10. Product Picture of Recombine Figure 11. Global Human Albumin Injection Sales Market Share by Type in 2022 Figure 12. Global Human Albumin Injection Revenue Market Share by Type (2018-2023) Figure 13. Human Albumin Injection Consumed in Hospital Figure 14. Global Human Albumin Injection Market: Hospital (2018-2023) & (K Units) Figure 15. Human Albumin Injection Consumed in Clinic Figure 16. Global Human Albumin Injection Market: Clinic (2018-2023) & (K Units) Figure 17. Global Human Albumin Injection Sales Market Share by Application (2022) Figure 18. Global Human Albumin Injection Revenue Market Share by Application in 2022 Figure 19. Human Albumin Injection Sales Market by Company in 2022 (K Units) Figure 20. Global Human Albumin Injection Sales Market Share by Company in 2022 Figure 21. Human Albumin Injection Revenue Market by Company in 2022 ($ Million) Figure 22. Global Human Albumin Injection Revenue Market Share by Company in 2022 Figure 23. Global Human Albumin Injection Sales Market Share by Geographic Region (2018-2023) Figure 24. Global Human Albumin Injection Revenue Market Share by Geographic Region in 2022 Figure 25. Americas Human Albumin Injection Sales 2018-2023 (K Units) Figure 26. Americas Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 27. APAC Human Albumin Injection Sales 2018-2023 (K Units) Figure 28. APAC Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 29. Europe Human Albumin Injection Sales 2018-2023 (K Units) Figure 30. Europe Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 31. Middle East & Africa Human Albumin Injection Sales 2018-2023 (K Units) Figure 32. Middle East & Africa Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 33. Americas Human Albumin Injection Sales Market Share by Country in 2022 Figure 34. Americas Human Albumin Injection Revenue Market Share by Country in 2022 Figure 35. Americas Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 36. Americas Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 37. United States Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 38. Canada Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 39. Mexico Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 40. Brazil Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 41. APAC Human Albumin Injection Sales Market Share by Region in 2022 Figure 42. APAC Human Albumin Injection Revenue Market Share by Regions in 2022 Figure 43. APAC Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 44. APAC Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 45. China Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 46. Japan Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 47. South Korea Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 48. Southeast Asia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 49. India Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 50. Australia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 51. China Taiwan Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 52. Europe Human Albumin Injection Sales Market Share by Country in 2022 Figure 53. Europe Human Albumin Injection Revenue Market Share by Country in 2022 Figure 54. Europe Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 55. Europe Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 56. Germany Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 57. France Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 58. UK Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 59. Italy Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 60. Russia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 61. Middle East & Africa Human Albumin Injection Sales Market Share by Country in 2022 Figure 62. Middle East & Africa Human Albumin Injection Revenue Market Share by Country in 2022 Figure 63. Middle East & Africa Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 64. Middle East & Africa Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 65. Egypt Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 66. South Africa Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 67. Israel Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 68. Turkey Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 69. GCC Country Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 70. Manufacturing Cost Structure Analysis of Human Albumin Injection in 2022 Figure 71. Manufacturing Process Analysis of Human Albumin Injection Figure 72. Industry Chain Structure of Human Albumin Injection Figure 73. Channels of Distribution Figure 74. Global Human Albumin Injection Sales Market Forecast by Region (2024-2029) Figure 75. Global Human Albumin Injection Revenue Market Share Forecast by Region (2024-2029) Figure 76. Global Human Albumin Injection Sales Market Share Forecast by Type (2024-2029) Figure 77. Global Human Albumin Injection Revenue Market Share Forecast by Type (2024-2029) Figure 78. Global Human Albumin Injection Sales Market Share Forecast by Application (2024-2029) Figure 79. Global Human Albumin Injection Revenue Market Share Forecast by Application (2024-2029)
SummaryThe global Human Albumin Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human Albumin Injection Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Human Albumin Injection by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Human Albumin Injection by Country/Region, 2018, 2022 & 2029 2.2 Human Albumin Injection Segment by Type 2.2.1 Blood Extraction 2.2.2 Recombine 2.3 Human Albumin Injection Sales by Type 2.3.1 Global Human Albumin Injection Sales Market Share by Type (2018-2023) 2.3.2 Global Human Albumin Injection Revenue and Market Share by Type (2018-2023) 2.3.3 Global Human Albumin Injection Sale Price by Type (2018-2023) 2.4 Human Albumin Injection Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Human Albumin Injection Sales by Application 2.5.1 Global Human Albumin Injection Sale Market Share by Application (2018-2023) 2.5.2 Global Human Albumin Injection Revenue and Market Share by Application (2018-2023) 2.5.3 Global Human Albumin Injection Sale Price by Application (2018-2023) 3 Global Human Albumin Injection by Company 3.1 Global Human Albumin Injection Breakdown Data by Company 3.1.1 Global Human Albumin Injection Annual Sales by Company (2018-2023) 3.1.2 Global Human Albumin Injection Sales Market Share by Company (2018-2023) 3.2 Global Human Albumin Injection Annual Revenue by Company (2018-2023) 3.2.1 Global Human Albumin Injection Revenue by Company (2018-2023) 3.2.2 Global Human Albumin Injection Revenue Market Share by Company (2018-2023) 3.3 Global Human Albumin Injection Sale Price by Company 3.4 Key Manufacturers Human Albumin Injection Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Human Albumin Injection Product Location Distribution 3.4.2 Players Human Albumin Injection Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Human Albumin Injection by Geographic Region 4.1 World Historic Human Albumin Injection Market Size by Geographic Region (2018-2023) 4.1.1 Global Human Albumin Injection Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Human Albumin Injection Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Human Albumin Injection Market Size by Country/Region (2018-2023) 4.2.1 Global Human Albumin Injection Annual Sales by Country/Region (2018-2023) 4.2.2 Global Human Albumin Injection Annual Revenue by Country/Region (2018-2023) 4.3 Americas Human Albumin Injection Sales Growth 4.4 APAC Human Albumin Injection Sales Growth 4.5 Europe Human Albumin Injection Sales Growth 4.6 Middle East & Africa Human Albumin Injection Sales Growth 5 Americas 5.1 Americas Human Albumin Injection Sales by Country 5.1.1 Americas Human Albumin Injection Sales by Country (2018-2023) 5.1.2 Americas Human Albumin Injection Revenue by Country (2018-2023) 5.2 Americas Human Albumin Injection Sales by Type 5.3 Americas Human Albumin Injection Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Human Albumin Injection Sales by Region 6.1.1 APAC Human Albumin Injection Sales by Region (2018-2023) 6.1.2 APAC Human Albumin Injection Revenue by Region (2018-2023) 6.2 APAC Human Albumin Injection Sales by Type 6.3 APAC Human Albumin Injection Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Human Albumin Injection by Country 7.1.1 Europe Human Albumin Injection Sales by Country (2018-2023) 7.1.2 Europe Human Albumin Injection Revenue by Country (2018-2023) 7.2 Europe Human Albumin Injection Sales by Type 7.3 Europe Human Albumin Injection Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Human Albumin Injection by Country 8.1.1 Middle East & Africa Human Albumin Injection Sales by Country (2018-2023) 8.1.2 Middle East & Africa Human Albumin Injection Revenue by Country (2018-2023) 8.2 Middle East & Africa Human Albumin Injection Sales by Type 8.3 Middle East & Africa Human Albumin Injection Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Human Albumin Injection 10.3 Manufacturing Process Analysis of Human Albumin Injection 10.4 Industry Chain Structure of Human Albumin Injection 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Human Albumin Injection Distributors 11.3 Human Albumin Injection Customer 12 World Forecast Review for Human Albumin Injection by Geographic Region 12.1 Global Human Albumin Injection Market Size Forecast by Region 12.1.1 Global Human Albumin Injection Forecast by Region (2024-2029) 12.1.2 Global Human Albumin Injection Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Human Albumin Injection Forecast by Type 12.7 Global Human Albumin Injection Forecast by Application 13 Key Players Analysis 13.1 Octapharma 13.1.1 Octapharma Company Information 13.1.2 Octapharma Human Albumin Injection Product Portfolios and Specifications 13.1.3 Octapharma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Octapharma Main Business Overview 13.1.5 Octapharma Latest Developments 13.2 CSL Behring 13.2.1 CSL Behring Company Information 13.2.2 CSL Behring Human Albumin Injection Product Portfolios and Specifications 13.2.3 CSL Behring Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 CSL Behring Main Business Overview 13.2.5 CSL Behring Latest Developments 13.3 Biotest (UK) Ltd 13.3.1 Biotest (UK) Ltd Company Information 13.3.2 Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications 13.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Biotest (UK) Ltd Main Business Overview 13.3.5 Biotest (UK) Ltd Latest Developments 13.4 Baxter 13.4.1 Baxter Company Information 13.4.2 Baxter Human Albumin Injection Product Portfolios and Specifications 13.4.3 Baxter Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Baxter Main Business Overview 13.4.5 Baxter Latest Developments 13.5 Kedrion Biopharma, Inc. 13.5.1 Kedrion Biopharma, Inc. Company Information 13.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications 13.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Kedrion Biopharma, Inc. Main Business Overview 13.5.5 Kedrion Biopharma, Inc. Latest Developments 13.6 Grifols 13.6.1 Grifols Company Information 13.6.2 Grifols Human Albumin Injection Product Portfolios and Specifications 13.6.3 Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Grifols Main Business Overview 13.6.5 Grifols Latest Developments 13.7 GE HealthCare 13.7.1 GE HealthCare Company Information 13.7.2 GE HealthCare Human Albumin Injection Product Portfolios and Specifications 13.7.3 GE HealthCare Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 GE HealthCare Main Business Overview 13.7.5 GE HealthCare Latest Developments 13.8 Bio Products Laboratory 13.8.1 Bio Products Laboratory Company Information 13.8.2 Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications 13.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Bio Products Laboratory Main Business Overview 13.8.5 Bio Products Laboratory Latest Developments 13.9 Green Cross 13.9.1 Green Cross Company Information 13.9.2 Green Cross Human Albumin Injection Product Portfolios and Specifications 13.9.3 Green Cross Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Green Cross Main Business Overview 13.9.5 Green Cross Latest Developments 13.10 SK Plasma 13.10.1 SK Plasma Company Information 13.10.2 SK Plasma Human Albumin Injection Product Portfolios and Specifications 13.10.3 SK Plasma Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 SK Plasma Main Business Overview 13.10.5 SK Plasma Latest Developments 13.11 Instituto Grifols 13.11.1 Instituto Grifols Company Information 13.11.2 Instituto Grifols Human Albumin Injection Product Portfolios and Specifications 13.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Instituto Grifols Main Business Overview 13.11.5 Instituto Grifols Latest Developments 13.12 Takeda 13.12.1 Takeda Company Information 13.12.2 Takeda Human Albumin Injection Product Portfolios and Specifications 13.12.3 Takeda Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Takeda Main Business Overview 13.12.5 Takeda Latest Developments 13.13 Hualan Bio 13.13.1 Hualan Bio Company Information 13.13.2 Hualan Bio Human Albumin Injection Product Portfolios and Specifications 13.13.3 Hualan Bio Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Hualan Bio Main Business Overview 13.13.5 Hualan Bio Latest Developments 13.14 Nanyue Biopharmaceuticals 13.14.1 Nanyue Biopharmaceuticals Company Information 13.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications 13.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Nanyue Biopharmaceuticals Main Business Overview 13.14.5 Nanyue Biopharmaceuticals Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Human Albumin Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Human Albumin Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Blood Extraction Table 4. Major Players of Recombine Table 5. Global Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 6. Global Human Albumin Injection Sales Market Share by Type (2018-2023) Table 7. Global Human Albumin Injection Revenue by Type (2018-2023) & ($ million) Table 8. Global Human Albumin Injection Revenue Market Share by Type (2018-2023) Table 9. Global Human Albumin Injection Sale Price by Type (2018-2023) & (US$/Unit) Table 10. Global Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 11. Global Human Albumin Injection Sales Market Share by Application (2018-2023) Table 12. Global Human Albumin Injection Revenue by Application (2018-2023) Table 13. Global Human Albumin Injection Revenue Market Share by Application (2018-2023) Table 14. Global Human Albumin Injection Sale Price by Application (2018-2023) & (US$/Unit) Table 15. Global Human Albumin Injection Sales by Company (2018-2023) & (K Units) Table 16. Global Human Albumin Injection Sales Market Share by Company (2018-2023) Table 17. Global Human Albumin Injection Revenue by Company (2018-2023) ($ Millions) Table 18. Global Human Albumin Injection Revenue Market Share by Company (2018-2023) Table 19. Global Human Albumin Injection Sale Price by Company (2018-2023) & (US$/Unit) Table 20. Key Manufacturers Human Albumin Injection Producing Area Distribution and Sales Area Table 21. Players Human Albumin Injection Products Offered Table 22. Human Albumin Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Human Albumin Injection Sales by Geographic Region (2018-2023) & (K Units) Table 26. Global Human Albumin Injection Sales Market Share Geographic Region (2018-2023) Table 27. Global Human Albumin Injection Revenue by Geographic Region (2018-2023) & ($ millions) Table 28. Global Human Albumin Injection Revenue Market Share by Geographic Region (2018-2023) Table 29. Global Human Albumin Injection Sales by Country/Region (2018-2023) & (K Units) Table 30. Global Human Albumin Injection Sales Market Share by Country/Region (2018-2023) Table 31. Global Human Albumin Injection Revenue by Country/Region (2018-2023) & ($ millions) Table 32. Global Human Albumin Injection Revenue Market Share by Country/Region (2018-2023) Table 33. Americas Human Albumin Injection Sales by Country (2018-2023) & (K Units) Table 34. Americas Human Albumin Injection Sales Market Share by Country (2018-2023) Table 35. Americas Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions) Table 36. Americas Human Albumin Injection Revenue Market Share by Country (2018-2023) Table 37. Americas Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 38. Americas Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 39. APAC Human Albumin Injection Sales by Region (2018-2023) & (K Units) Table 40. APAC Human Albumin Injection Sales Market Share by Region (2018-2023) Table 41. APAC Human Albumin Injection Revenue by Region (2018-2023) & ($ Millions) Table 42. APAC Human Albumin Injection Revenue Market Share by Region (2018-2023) Table 43. APAC Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 44. APAC Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 45. Europe Human Albumin Injection Sales by Country (2018-2023) & (K Units) Table 46. Europe Human Albumin Injection Sales Market Share by Country (2018-2023) Table 47. Europe Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions) Table 48. Europe Human Albumin Injection Revenue Market Share by Country (2018-2023) Table 49. Europe Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 50. Europe Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 51. Middle East & Africa Human Albumin Injection Sales by Country (2018-2023) & (K Units) Table 52. Middle East & Africa Human Albumin Injection Sales Market Share by Country (2018-2023) Table 53. Middle East & Africa Human Albumin Injection Revenue by Country (2018-2023) & ($ Millions) Table 54. Middle East & Africa Human Albumin Injection Revenue Market Share by Country (2018-2023) Table 55. Middle East & Africa Human Albumin Injection Sales by Type (2018-2023) & (K Units) Table 56. Middle East & Africa Human Albumin Injection Sales by Application (2018-2023) & (K Units) Table 57. Key Market Drivers & Growth Opportunities of Human Albumin Injection Table 58. Key Market Challenges & Risks of Human Albumin Injection Table 59. Key Industry Trends of Human Albumin Injection Table 60. Human Albumin Injection Raw Material Table 61. Key Suppliers of Raw Materials Table 62. Human Albumin Injection Distributors List Table 63. Human Albumin Injection Customer List Table 64. Global Human Albumin Injection Sales Forecast by Region (2024-2029) & (K Units) Table 65. Global Human Albumin Injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 66. Americas Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units) Table 67. Americas Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 68. APAC Human Albumin Injection Sales Forecast by Region (2024-2029) & (K Units) Table 69. APAC Human Albumin Injection Revenue Forecast by Region (2024-2029) & ($ millions) Table 70. Europe Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units) Table 71. Europe Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 72. Middle East & Africa Human Albumin Injection Sales Forecast by Country (2024-2029) & (K Units) Table 73. Middle East & Africa Human Albumin Injection Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Global Human Albumin Injection Sales Forecast by Type (2024-2029) & (K Units) Table 75. Global Human Albumin Injection Revenue Forecast by Type (2024-2029) & ($ Millions) Table 76. Global Human Albumin Injection Sales Forecast by Application (2024-2029) & (K Units) Table 77. Global Human Albumin Injection Revenue Forecast by Application (2024-2029) & ($ Millions) Table 78. Octapharma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 79. Octapharma Human Albumin Injection Product Portfolios and Specifications Table 80. Octapharma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 81. Octapharma Main Business Table 82. Octapharma Latest Developments Table 83. CSL Behring Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 84. CSL Behring Human Albumin Injection Product Portfolios and Specifications Table 85. CSL Behring Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 86. CSL Behring Main Business Table 87. CSL Behring Latest Developments Table 88. Biotest (UK) Ltd Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 89. Biotest (UK) Ltd Human Albumin Injection Product Portfolios and Specifications Table 90. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 91. Biotest (UK) Ltd Main Business Table 92. Biotest (UK) Ltd Latest Developments Table 93. Baxter Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 94. Baxter Human Albumin Injection Product Portfolios and Specifications Table 95. Baxter Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 96. Baxter Main Business Table 97. Baxter Latest Developments Table 98. Kedrion Biopharma, Inc. Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 99. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolios and Specifications Table 100. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 101. Kedrion Biopharma, Inc. Main Business Table 102. Kedrion Biopharma, Inc. Latest Developments Table 103. Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 104. Grifols Human Albumin Injection Product Portfolios and Specifications Table 105. Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 106. Grifols Main Business Table 107. Grifols Latest Developments Table 108. GE HealthCare Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 109. GE HealthCare Human Albumin Injection Product Portfolios and Specifications Table 110. GE HealthCare Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 111. GE HealthCare Main Business Table 112. GE HealthCare Latest Developments Table 113. Bio Products Laboratory Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 114. Bio Products Laboratory Human Albumin Injection Product Portfolios and Specifications Table 115. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 116. Bio Products Laboratory Main Business Table 117. Bio Products Laboratory Latest Developments Table 118. Green Cross Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 119. Green Cross Human Albumin Injection Product Portfolios and Specifications Table 120. Green Cross Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 121. Green Cross Main Business Table 122. Green Cross Latest Developments Table 123. SK Plasma Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 124. SK Plasma Human Albumin Injection Product Portfolios and Specifications Table 125. SK Plasma Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 126. SK Plasma Main Business Table 127. SK Plasma Latest Developments Table 128. Instituto Grifols Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 129. Instituto Grifols Human Albumin Injection Product Portfolios and Specifications Table 130. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 131. Instituto Grifols Main Business Table 132. Instituto Grifols Latest Developments Table 133. Takeda Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 134. Takeda Human Albumin Injection Product Portfolios and Specifications Table 135. Takeda Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 136. Takeda Main Business Table 137. Takeda Latest Developments Table 138. Hualan Bio Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 139. Hualan Bio Human Albumin Injection Product Portfolios and Specifications Table 140. Hualan Bio Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 141. Hualan Bio Main Business Table 142. Hualan Bio Latest Developments Table 143. Nanyue Biopharmaceuticals Basic Information, Human Albumin Injection Manufacturing Base, Sales Area and Its Competitors Table 144. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolios and Specifications Table 145. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 146. Nanyue Biopharmaceuticals Main Business Table 147. Nanyue Biopharmaceuticals Latest Developments List of Figures Figure 1. Picture of Human Albumin Injection Figure 2. Human Albumin Injection Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Human Albumin Injection Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Human Albumin Injection Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Human Albumin Injection Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Blood Extraction Figure 10. Product Picture of Recombine Figure 11. Global Human Albumin Injection Sales Market Share by Type in 2022 Figure 12. Global Human Albumin Injection Revenue Market Share by Type (2018-2023) Figure 13. Human Albumin Injection Consumed in Hospital Figure 14. Global Human Albumin Injection Market: Hospital (2018-2023) & (K Units) Figure 15. Human Albumin Injection Consumed in Clinic Figure 16. Global Human Albumin Injection Market: Clinic (2018-2023) & (K Units) Figure 17. Global Human Albumin Injection Sales Market Share by Application (2022) Figure 18. Global Human Albumin Injection Revenue Market Share by Application in 2022 Figure 19. Human Albumin Injection Sales Market by Company in 2022 (K Units) Figure 20. Global Human Albumin Injection Sales Market Share by Company in 2022 Figure 21. Human Albumin Injection Revenue Market by Company in 2022 ($ Million) Figure 22. Global Human Albumin Injection Revenue Market Share by Company in 2022 Figure 23. Global Human Albumin Injection Sales Market Share by Geographic Region (2018-2023) Figure 24. Global Human Albumin Injection Revenue Market Share by Geographic Region in 2022 Figure 25. Americas Human Albumin Injection Sales 2018-2023 (K Units) Figure 26. Americas Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 27. APAC Human Albumin Injection Sales 2018-2023 (K Units) Figure 28. APAC Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 29. Europe Human Albumin Injection Sales 2018-2023 (K Units) Figure 30. Europe Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 31. Middle East & Africa Human Albumin Injection Sales 2018-2023 (K Units) Figure 32. Middle East & Africa Human Albumin Injection Revenue 2018-2023 ($ Millions) Figure 33. Americas Human Albumin Injection Sales Market Share by Country in 2022 Figure 34. Americas Human Albumin Injection Revenue Market Share by Country in 2022 Figure 35. Americas Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 36. Americas Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 37. United States Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 38. Canada Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 39. Mexico Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 40. Brazil Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 41. APAC Human Albumin Injection Sales Market Share by Region in 2022 Figure 42. APAC Human Albumin Injection Revenue Market Share by Regions in 2022 Figure 43. APAC Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 44. APAC Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 45. China Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 46. Japan Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 47. South Korea Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 48. Southeast Asia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 49. India Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 50. Australia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 51. China Taiwan Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 52. Europe Human Albumin Injection Sales Market Share by Country in 2022 Figure 53. Europe Human Albumin Injection Revenue Market Share by Country in 2022 Figure 54. Europe Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 55. Europe Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 56. Germany Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 57. France Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 58. UK Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 59. Italy Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 60. Russia Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 61. Middle East & Africa Human Albumin Injection Sales Market Share by Country in 2022 Figure 62. Middle East & Africa Human Albumin Injection Revenue Market Share by Country in 2022 Figure 63. Middle East & Africa Human Albumin Injection Sales Market Share by Type (2018-2023) Figure 64. Middle East & Africa Human Albumin Injection Sales Market Share by Application (2018-2023) Figure 65. Egypt Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 66. South Africa Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 67. Israel Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 68. Turkey Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 69. GCC Country Human Albumin Injection Revenue Growth 2018-2023 ($ Millions) Figure 70. Manufacturing Cost Structure Analysis of Human Albumin Injection in 2022 Figure 71. Manufacturing Process Analysis of Human Albumin Injection Figure 72. Industry Chain Structure of Human Albumin Injection Figure 73. Channels of Distribution Figure 74. Global Human Albumin Injection Sales Market Forecast by Region (2024-2029) Figure 75. Global Human Albumin Injection Revenue Market Share Forecast by Region (2024-2029) Figure 76. Global Human Albumin Injection Sales Market Share Forecast by Type (2024-2029) Figure 77. Global Human Albumin Injection Revenue Market Share Forecast by Type (2024-2029) Figure 78. Global Human Albumin Injection Sales Market Share Forecast by Application (2024-2029) Figure 79. Global Human Albumin Injection Revenue Market Share Forecast by Application (2024-2029)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポートLP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(albumin)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |